Alnylam gets FDA OK to restart hemophilia drug trial after patient's death By: Boston Business Journal via Business Journals December 15, 2017 at 10:16 AM EST The Cambridge biotech says the FDA had lifted a clinical hold that was announced in September. Read More >>
